Noticias de SRPT_US

Noticias del mercado

Últimas noticias sobre SRPT_US — 139 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: SRPT_US ✕ 139 resultados
03/04/2026 SRPT_US — JD Supra
The Precedent: Federal Circuit Upholds Gene Therapy Host Cell Claims Under 35 U.S.C. § 101 in Regenxbio Inc., Et Al. v. Sarepta Therapeutics, Inc., Et Al.
31/03/2026 SRPT_US — Yahoo Finance
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
31/03/2026 SRPT_US — Business Wire
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
29/03/2026 SRPT_US — MSN ES ← EN
¿Por qué Sarepta Therapeutics (SRPT) ha subido un 24,2 % desde el último informe de resultados?
29/03/2026 SRPT_US — MSN
Sarepta plans FDA filings seeking full approval for two DMD therapies
27/03/2026 SRPT_US — MSN
Why is Sarepta Therapeutics (SRPT) up 24.2% since last earnings report?
27/03/2026 SRPT_US — Yahoo Finance
Why Is Sarepta Therapeutics (SRPT) Up 24.2% Since Last Earnings Report?
27/03/2026 SRPT_US — Stock Titan
Vanguard realigns reporting; reports 0 shares of Sarepta (SRPT)
26/03/2026 SRPT_US — Steptoe
Federal Circuit Holds Gene Therapy Claims Patent Eligible in REGENXBIO v. Sarepta
26/03/2026 SRPT_US — Seeking Alpha
Sarepta Therapeutics - It's Too Early To Get Excited About siRNA Data (NASDAQ:SRPT)
26/03/2026 SRPT_US — Yahoo Finance
Sarepta Therapeutics (SRPT) Soars 35.0%: Is Further Upside Left in the Stock?
25/03/2026 SRPT_US — Benzinga
Why Is Sarepta Therapeutics Stock Exploding Today?
25/03/2026 SRPT_US — Yahoo Finance
Sarepta Therapeutics’ experimental siRNA therapies show promising early results
25/03/2026 SRPT_US — Business Wire
Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
25/03/2026 SRPT_US — MEXC
Sarepta Therapeutics (SRPT) Stock Climbs Following Positive siRNA Muscular Dystrophy Trial Results
25/03/2026 SRPT_US — BioSpace
Sarepta to Share First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
25/03/2026 SRPT_US — Proactive financial news
Sarepta Therapeutics’ experimental siRNA therapies show promising early results
25/03/2026 SRPT_US — Yahoo Finance
Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
25/03/2026 SRPT_US — Seeking Alpha
Sarepta posts data for muscular dystrophy drugs (SRPT:NASDAQ)
25/03/2026 SRPT_US — 24/7 Wall St.
Sarepta Therapeutics Zooms 20% Higher on Promising Clinical Data: Is SRPT Ready for a Bigger Breakout?

Página 5 de 7

keyboard_arrow_up